BDBM50216428 CHEMBL393632::N-(4-(3,4-dichlorobenzamido)benzyl)-N,N-dimethyl(tetrahydro-2H-pyran-4-yl)methanaminium
SMILES: C[N+](C)(CC1CCOCC1)Cc1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1
InChI Key: InChIKey=WZFXYQUWHHPOHX-UHFFFAOYSA-O
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-C chemokine receptor type 2 (Homo sapiens (Human)) | BDBM50216428 (CHEMBL393632 | N-(4-(3,4-dichlorobenzamido)benzyl)...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 1.02E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL | Assay Description Displacement of [125I]MCP1 from CCR2 receptor expressed in THP1 cells | Bioorg Med Chem Lett 17: 4382-6 (2007) Article DOI: 10.1016/j.bmcl.2007.01.115 BindingDB Entry DOI: 10.7270/Q2F47NVR | |||||||||||
More data for this Ligand-Target Pair |